Panel Discussion: Overviewing the Greatest Risks Posed by Lipid Nanoparticles to Mitigate Adverse Affect Occurence
Time: 2:30 pm
day: Conference Day One
Details:
- Sharing insights into the adverse affects recorded across the literature and triaging the common causes of such events
- Spotlighting steps of formulation which require greatest attention to control the toxicity profile of the LNP
- Considering bioaccumulation of LNPs and the types of therapeutics and target sites which increase this risk
